financetom
Business
financetom
/
Business
/
BRIEF-GATX Corporation And Brookfield Infrastructure To Acquire Wells Fargo'S Rail Assets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-GATX Corporation And Brookfield Infrastructure To Acquire Wells Fargo'S Rail Assets
May 29, 2025 2:34 PM

May 29 (Reuters) - GATX Corp ( GATX ):

* GATX CORPORATION AND BROOKFIELD INFRASTRUCTURE TO ACQUIRE

WELLS

FARGO'S RAIL ASSETS

* GATX CORP ( GATX ) - TO BUY 105,000 RAILCARS FOR $4.4 BILLION

* GATX CORP ( GATX ) - JOINT VENTURE TO BUY 105,000 RAILCARS FROM

WELLS

FARGO

* GATX CORP ( GATX ) - TO HOLD 30% INITIAL EQUITY IN JOINT VENTURE

* GATX CORP ( GATX ) - TO CONTRIBUTE $400 MILLION IN INITIAL EQUITY

* GATX CORP ( GATX ) - JOINT VENTURE SECURES $3.2 BILLION TERM LOAN

AND

$250 MILLION CREDIT FACILITY

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kenvue Reaches Accord With Activist Investor Starboard Value, Adds 3 New Board Members
Kenvue Reaches Accord With Activist Investor Starboard Value, Adds 3 New Board Members
Mar 5, 2025
11:21 AM EST, 03/05/2025 (MT Newswires) -- Kenvue ( KVUE ) on Wednesday named three new members to its board as part of a cooperation agreement with activist investor Starboard Value. Under the agreement, Starboard will withdraw its slate of nominated director candidates and vote all of its shares in favor of Kenvue ( KVUE ) board nominees, the companies...
Amgen Launches Two Phase 3 Trials for Obesity Drug MariTide
Amgen Launches Two Phase 3 Trials for Obesity Drug MariTide
Mar 5, 2025
11:25 AM EST, 03/05/2025 (MT Newswires) -- Amgen ( AMGN ) has initiated two phase 3 trials for its obesity drug MariTide, the company's Head of Research and Development, Jay Bradner, said Wednesday at an investor conference. One of the trials is in people with obesity or overweight without type 2 diabetes, and is expected to enroll 3,500 people, Bradner...
Pluri, Hemafund Sign Exclusive Collaboration Deal on Potential Radiation Treatment; Shares Rise
Pluri, Hemafund Sign Exclusive Collaboration Deal on Potential Radiation Treatment; Shares Rise
Mar 5, 2025
11:23 AM EST, 03/05/2025 (MT Newswires) -- Pluri ( PLUR ) said Wednesday that it signed an exclusive collaboration deal with Hemafund, an umbilical cord blood bank, for the distribution and clinical advancement of PLX-R18 cell therapy as a potential treatment for Hematopoietic Acute Radiation Syndrome in Ukraine. Pluri ( PLUR ) said it has agreed to produce and supply...
Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court
Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court
Mar 5, 2025
11:28 AM EST, 03/05/2025 (MT Newswires) -- Pfizer ( PFE ) and its partner BioNTech (BNTX) have infringed a COVID-19 vaccine patent owned by Moderna ( MRNA ) , Reuters reported Wednesday, citing a German court ruling. The court reportedly ordered Pfizer ( PFE ) and BioNTech to disclose earnings related to the patent's use and pay a compensation to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved